News

AddToAny

Google+ Facebook Twitter Twitter

Label-free histopathology

A research team has developed a machine learning-based label-free histopathology device that can perform histopathology in real time.

It avoids freezing, sectioning, or staining by using the ultraviolet (UV) photoacoustic imaging technology (UV-MEMS PAM) that converges ultra-high-speed MEMS scanner technology.

The researchers proposed a high-speed reflection-mode UV photoacoustic microscopy system using the 1-axis MEMS scanner as a novel label-free intraoperative histopathology method.

They succeeded in visualising label-free cell nuclei of mouse and human tissues using this approach.

In addition, by imaging clinical specimens resected from actual cancer patients and numerically quantifying the histopathological results, the research team successfully demonstrated that the proposed UV-PAM system has great potential as an alternative intraoperative histopathology method.

The device enables 3D imaging without an independent contrast agent and can achieve structural and functional imaging of small cells.

bit.ly/3DqvtDe

Image Credit | Poshtech

Related Articles

illustration_CREDIT_istock-484714523

Advanced and consultant practice roles

Sarah May and Chris Ward from the IBMS look at advanced and consultant roles and discuss new developments and qualifications.

Robotic hand with handgun aiming in wrong direction. Fatal AI error - Image credit - Shutterstock-2309476357

Tissue contamination distracts AI

In a new study, scientists trained three AI models to scan microscope slides of placenta tissue to detect blood vessel damage, estimate gestational age and classify macroscopic lesions.

Digital pathology cleared for use-history digital pathology-CREDIT-university of warwick

Digital pathology cleared for use

New research has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.

Breast cancer 3D tomography-CREDIT-Science-Photo-Library-c0303374

Two decades of hHER2 testing

This year marks the 20th anniversary of Her2 breast cancer testing at the Royal Cornwall Hospital. Senior Biomedical Scientist Mary Jones looks back over the past two decades.

Top